NPI: 1851346720 · ASHLAND, KY 41101 · Rural Health Clinic/Center · NPI assigned 05/22/2006
Authorized official MARKS, SARA controls 20+ related entities in our dataset. Read more
| Authorized Official | MARKS, SARA (CEO) |
| NPI Enumeration Date | 05/22/2006 |
Other providers sharing the same authorized official: MARKS, SARA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 643,069 | $23.96M |
| 2019 | 659,562 | $22.51M |
| 2020 | 687,447 | $23.78M |
| 2021 | 1,000,133 | $34.33M |
| 2022 | 1,100,101 | $37.51M |
| 2023 | 1,274,562 | $42.60M |
| 2024 | 1,142,729 | $38.09M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 800,710 | 679,877 | $24.50M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 499,500 | 411,957 | $17.81M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 152,837 | 126,724 | $10.52M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 49,198 | 33,119 | $9.52M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 61,569 | 45,006 | $7.51M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 35,592 | 20,042 | $6.21M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 358,800 | 267,474 | $5.80M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9,927 | 8,389 | $4.10M |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 9,764 | 4,913 | $3.95M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 10,383 | 6,478 | $3.83M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 11,537 | 9,223 | $3.44M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 11,961 | 10,666 | $3.23M |
| 47562 | 1,849 | 1,139 | $2.67M | |
| 93458 | 3,961 | 1,627 | $2.66M | |
| G0378 | Hospital observation service, per hour | 14,483 | 10,228 | $2.23M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 17,905 | 14,357 | $2.18M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 118,693 | 99,448 | $2.16M |
| J2357 | Injection, omalizumab, 5 mg | 4,767 | 1,569 | $2.14M |
| 80053 | Comprehensive metabolic panel | 290,153 | 155,825 | $2.07M |
| 71046 | Radiologic examination, chest; 2 views | 46,765 | 36,969 | $2.01M |
| 70450 | Computed tomography, head or brain; without contrast material | 10,963 | 9,315 | $1.82M |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 4,752 | 3,946 | $1.75M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 29,024 | 12,412 | $1.73M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 3,700 | 2,571 | $1.72M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 2,213 | 1,898 | $1.52M |
| 80050 | General health panel | 25,622 | 20,523 | $1.43M |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 2,585 | 1,910 | $1.43M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 2,992 | 2,387 | $1.29M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 31,695 | 24,131 | $1.28M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 42,431 | 37,571 | $1.28M |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 143,662 | 80,419 | $1.22M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 227,370 | 173,286 | $1.20M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 19,869 | 13,961 | $1.18M |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 3,298 | 2,605 | $1.15M |
| 71250 | 6,861 | 5,102 | $1.15M | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 35,307 | 8,856 | $1.12M |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 31,991 | 22,507 | $1.12M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 11,559 | 10,745 | $1.09M |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 7,256 | 6,690 | $1.07M |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 49,422 | 42,609 | $1.07M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 918 | 828 | $1.05M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 50,607 | 47,514 | $1.03M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 11,002 | 4,561 | $1.02M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 29,340 | 28,342 | $1.02M |
| 72141 | 2,356 | 1,936 | $989K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 28,092 | 19,320 | $965K |
| 62323 | 2,095 | 1,237 | $960K | |
| 95811 | 1,459 | 1,316 | $956K | |
| 58571 | 423 | 177 | $953K | |
| 93017 | 6,003 | 5,538 | $938K | |
| 58661 | 524 | 388 | $926K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 31,653 | 22,530 | $879K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 1,757 | 1,319 | $879K |
| 76536 | 4,460 | 4,084 | $866K | |
| 95911 | 1,451 | 1,336 | $858K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 100,465 | 82,717 | $847K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 14,945 | 12,547 | $842K |
| 74018 | 9,543 | 8,344 | $834K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 1,964 | 1,731 | $814K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 51,853 | 42,399 | $788K |
| 72100 | 8,646 | 7,321 | $781K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1,191 | 1,077 | $778K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 11,214 | 9,441 | $760K |
| 36415 | Collection of venous blood by venipuncture | 244,515 | 145,825 | $734K |
| 96375 | Therapeutic injection; each additional sequential IV push | 26,432 | 18,776 | $718K |
| 71045 | Radiologic examination, chest; single view | 31,401 | 23,427 | $715K |
| 80061 | Lipid panel | 71,258 | 59,465 | $698K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 2,920 | 2,004 | $687K |
| 73630 | 11,488 | 9,583 | $681K | |
| S9128 | Speech therapy, in the home, per diem | 9,415 | 3,257 | $659K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,555 | 2,196 | $656K |
| 84443 | Thyroid stimulating hormone (TSH) | 54,607 | 50,886 | $652K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11,807 | 10,976 | $645K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 31,840 | 28,511 | $634K |
| 73610 | 9,808 | 8,233 | $620K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 10,125 | 9,844 | $611K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 4,081 | 3,668 | $609K |
| J9271 | Injection, pembrolizumab, 1 mg | 140 | 87 | $608K |
| 73030 | 10,140 | 8,220 | $584K | |
| 93226 | 4,185 | 3,897 | $577K | |
| 73130 | 9,401 | 7,889 | $570K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 83,570 | 79,372 | $563K |
| 73562 | 8,127 | 6,856 | $547K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 12,306 | 7,127 | $530K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 40,826 | 31,485 | $502K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 14,375 | 4,692 | $487K |
| 73110 | 7,899 | 6,214 | $486K | |
| 95886 | 3,034 | 2,650 | $484K | |
| 0223U | 2,246 | 2,078 | $484K | |
| 90461 | 14,655 | 14,169 | $480K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 18,068 | 15,738 | $460K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 8,230 | 4,239 | $454K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 403 | 228 | $448K |
| 80048 | Basic metabolic panel (calcium, ionized) | 68,808 | 41,264 | $445K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2,031 | 1,893 | $431K |
| 00731 | 4,596 | 4,026 | $418K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6,952 | 6,770 | $417K |
| D2930 | Prefabricated stainless steel crown - primary tooth | 764 | 133 | $414K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 15,506 | 13,013 | $411K |
| 95909 | 1,344 | 1,206 | $409K | |
| 96367 | 10,425 | 3,276 | $396K | |
| 82607 | 34,977 | 31,379 | $395K | |
| 70486 | 1,679 | 1,396 | $391K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 11,006 | 6,369 | $390K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,350 | 1,838 | $383K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 13,159 | 12,050 | $377K |
| 93971 | 3,659 | 3,265 | $375K | |
| 52000 | 1,378 | 1,012 | $373K | |
| S9129 | Occupational therapy, in the home, per diem | 5,577 | 1,808 | $372K |
| 94060 | 4,468 | 2,847 | $369K | |
| 93225 | 3,218 | 2,786 | $361K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 13,064 | 12,025 | $357K |
| 49083 | 1,127 | 305 | $351K | |
| 78227 | 752 | 558 | $343K | |
| 00813 | 3,682 | 3,083 | $339K | |
| 87902 | 1,854 | 1,479 | $337K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 48,453 | 45,132 | $333K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 14,684 | 4,986 | $332K |
| 76775 | 2,417 | 2,178 | $332K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 52,464 | 42,550 | $331K |
| 84484 | 33,612 | 22,125 | $306K | |
| 73560 | 7,518 | 6,095 | $305K | |
| 30140 | 360 | 311 | $301K | |
| 00840 | 2,936 | 2,240 | $297K | |
| 73221 | 855 | 709 | $291K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 16,958 | 15,581 | $288K |
| 76830 | Ultrasound, transvaginal | 2,867 | 2,642 | $286K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1,307 | 1,189 | $280K |
| 95885 | 1,763 | 1,509 | $276K | |
| 88342 | 4,097 | 3,333 | $270K | |
| 84439 | 33,164 | 30,809 | $266K | |
| 99173 | 10,219 | 9,953 | $260K | |
| 80074 | 8,160 | 7,004 | $255K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 31,968 | 26,510 | $254K |
| 72040 | 4,281 | 3,583 | $252K | |
| 82947 | 35,170 | 17,967 | $246K | |
| 96415 | 3,073 | 1,647 | $243K | |
| 88341 | 1,842 | 1,529 | $242K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 2,500 | 2,214 | $240K |
| 96376 | 12,388 | 6,022 | $236K | |
| 70496 | 831 | 635 | $233K | |
| 76642 | 2,407 | 2,168 | $233K | |
| 73080 | 3,895 | 3,193 | $231K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 9,871 | 9,467 | $227K |
| 86003 | 3,069 | 2,407 | $227K | |
| 78816 | 293 | 216 | $226K | |
| 97162 | 6,875 | 4,166 | $224K | |
| 93975 | 1,462 | 1,342 | $221K | |
| 70498 | 782 | 691 | $215K | |
| 77066 | Tomosynthesis, mammo | 1,794 | 1,679 | $213K |
| 72070 | 3,034 | 2,528 | $209K | |
| S9131 | Physical therapy; in the home, per diem | 3,422 | 1,057 | $209K |
| 99215 | Prolong outpt/office vis | 6,640 | 5,715 | $209K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 7,554 | 2,655 | $205K |
| 00126 | 1,568 | 1,498 | $201K | |
| 95816 | 1,063 | 982 | $198K | |
| 94010 | 2,331 | 1,704 | $197K | |
| 94729 | 3,291 | 3,154 | $196K | |
| 74183 | 430 | 355 | $196K | |
| J2785 | Injection, regadenoson, 0.1 mg | 3,305 | 3,012 | $194K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2,768 | 2,700 | $192K |
| 00811 | 1,902 | 1,709 | $190K | |
| 71101 | 2,987 | 2,355 | $190K | |
| 93880 | 1,064 | 951 | $187K | |
| 84145 | 12,519 | 10,143 | $187K | |
| 87522 | Neg quan hep c or qual rna | 4,995 | 4,607 | $186K |
| 88307 | 2,279 | 1,642 | $183K | |
| 90791 | Psychiatric diagnostic evaluation | 3,551 | 3,058 | $180K |
| 94726 | 2,850 | 2,622 | $178K | |
| 43235 | 524 | 357 | $177K | |
| 00790 | 1,655 | 1,477 | $174K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 6,294 | 5,182 | $174K |
| 29580 | 3,234 | 1,231 | $174K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 825 | 784 | $173K |
| 36591 | 9,901 | 3,743 | $166K | |
| 77065 | Tomosynthesis, mammo | 2,048 | 1,790 | $159K |
| 30520 | 228 | 190 | $157K | |
| 97597 | 5,011 | 3,550 | $153K | |
| 85610 | 41,579 | 28,305 | $153K | |
| 82728 | 15,414 | 13,005 | $151K | |
| J0897 | Injection, denosumab, 1 mg | 585 | 337 | $149K |
| 83880 | 9,063 | 7,691 | $149K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 13,068 | 11,049 | $147K |
| 73502 | 5,390 | 4,349 | $147K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 8,326 | 5,660 | $146K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 672 | 471 | $143K |
| 73620 | 1,903 | 1,654 | $143K | |
| 83735 | 34,844 | 25,734 | $143K | |
| 93970 | 563 | 523 | $142K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 2,418 | 1,337 | $140K |
| 52310 | 211 | 164 | $139K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 33,332 | 23,639 | $139K |
| 73590 | 2,700 | 2,204 | $136K | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 7,413 | 5,063 | $136K |
| 86235 | 3,427 | 1,786 | $132K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 4,462 | 4,375 | $131K |
| 64721 | 140 | 108 | $131K | |
| 81001 | 53,263 | 46,514 | $129K | |
| 74178 | 194 | 167 | $128K | |
| 58558 | 119 | 86 | $128K | |
| 97803 | 4,234 | 4,078 | $126K | |
| 99152 | 2,310 | 1,970 | $126K | |
| 86703 | 10,045 | 9,199 | $126K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 2,003 | 1,768 | $124K |
| 87081 | 18,452 | 17,248 | $123K | |
| J2704 | Injection, propofol, 10 mg | 46,125 | 24,769 | $123K |
| 76870 | 1,022 | 923 | $123K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 4,678 | 1,647 | $122K |
| 83550 | 17,480 | 16,365 | $121K | |
| 83605 | 16,367 | 13,786 | $119K | |
| 74022 | 1,273 | 1,176 | $118K | |
| 88304 | 3,308 | 2,857 | $116K | |
| 74450 | 710 | 641 | $112K | |
| 92557 | 3,091 | 2,561 | $111K | |
| 73140 | 2,186 | 1,872 | $109K | |
| 0225U | 569 | 534 | $107K | |
| 86803 | 9,558 | 8,840 | $106K | |
| 72131 | 926 | 664 | $106K | |
| 92551 | 10,179 | 9,911 | $105K | |
| 87150 | 3,535 | 3,325 | $102K | |
| 83690 | 19,179 | 16,784 | $101K | |
| 84703 | 21,564 | 18,899 | $100K | |
| 73090 | 2,050 | 1,659 | $99K | |
| 77080 | 2,019 | 1,426 | $99K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 8,120 | 7,403 | $99K |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | 189 | 56 | $98K |
| D7140 | Extraction, erupted tooth or exposed root | 464 | 112 | $98K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 3,483 | 2,909 | $97K |
| 71271 | 1,944 | 1,751 | $97K | |
| 78264 | 439 | 284 | $96K | |
| 86850 | 10,182 | 8,571 | $96K | |
| 93016 | 7,197 | 6,786 | $94K | |
| 87505 | 1,103 | 1,045 | $93K | |
| 93308 | 561 | 483 | $93K | |
| 87186 | 14,508 | 12,608 | $93K | |
| 81025 | 11,627 | 10,043 | $92K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 65,027 | 51,014 | $92K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1,639 | 1,566 | $92K |
| 86140 | 19,484 | 16,966 | $92K | |
| 97802 | 2,162 | 2,066 | $91K | |
| 82746 | 7,858 | 7,352 | $90K | |
| 75574 | 358 | 282 | $87K | |
| 86780 | 8,515 | 7,703 | $86K | |
| 96417 | 1,794 | 1,008 | $85K | |
| 84702 | 7,029 | 5,185 | $82K | |
| 86480 | 1,869 | 1,717 | $81K | |
| 00910 | 721 | 607 | $80K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 161 | 26 | $79K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 260 | 136 | $77K |
| 91200 | 1,344 | 1,288 | $77K | |
| 86900 | 12,402 | 8,820 | $77K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 9,490 | 7,256 | $75K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2,891 | 2,608 | $75K |
| 00160 | 611 | 543 | $72K | |
| 84153 | 5,439 | 5,084 | $70K | |
| 84403 | 3,514 | 3,235 | $69K | |
| 83970 | 2,587 | 2,330 | $69K | |
| 87807 | 10,980 | 10,407 | $68K | |
| 85730 | 16,892 | 14,628 | $68K | |
| 87631 | 590 | 558 | $68K | |
| 99442 | 2,533 | 2,353 | $67K | |
| 70491 | 314 | 237 | $67K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 32,180 | 22,422 | $67K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,112 | 1,915 | $67K |
| 87040 | 7,990 | 5,107 | $67K | |
| 64493 | 443 | 247 | $66K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 397 | 229 | $66K |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 244 | 201 | $65K |
| 95806 | 676 | 622 | $63K | |
| 87340 | 7,076 | 6,445 | $62K | |
| 52281 | 141 | 75 | $62K | |
| 99441 | 3,674 | 3,374 | $62K | |
| 87070 | 8,535 | 5,952 | $62K | |
| 93018 | 6,456 | 6,130 | $61K | |
| J3490 | Unclassified drugs | 6,553 | 4,908 | $61K |
| 00812 | 550 | 508 | $61K | |
| J1756 | Injection, iron sucrose, 1 mg | 2,577 | 696 | $60K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 384 | 356 | $60K |
| 99238 | Hospital discharge day management, 30 minutes or less | 1,283 | 1,204 | $60K |
| 99460 | 1,293 | 1,240 | $60K | |
| 86762 | 5,053 | 4,582 | $59K | |
| 85379 | 9,807 | 8,758 | $59K | |
| 95913 | 71 | 65 | $58K | |
| 93922 | 682 | 633 | $58K | |
| 81003 | 46,453 | 35,965 | $58K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2,612 | 1,884 | $58K |
| 74246 | 818 | 742 | $57K | |
| 96368 | 2,497 | 1,283 | $57K | |
| J1453 | Injection, fosaprepitant, 1 mg | 1,872 | 1,073 | $56K |
| 73521 | 773 | 681 | $56K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 36,195 | 29,166 | $56K |
| 82077 | 6,566 | 5,541 | $55K | |
| 86376 | 4,553 | 4,303 | $55K | |
| 27096 | 100 | 86 | $55K | |
| 86901 | 9,968 | 8,586 | $53K | |
| 88300 | 2,174 | 2,002 | $52K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 10,711 | 7,929 | $52K |
| 82043 | 11,166 | 10,087 | $51K | |
| J1644 | Injection, heparin sodium, per 1000 units | 11,404 | 4,910 | $51K |
| 62321 | 96 | 70 | $51K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | 10,284 | 7,491 | $51K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 819 | 707 | $51K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 151 | 84 | $48K |
| J7050 | Infusion, normal saline solution, 250 cc | 10,615 | 5,877 | $47K |
| 86038 | 4,647 | 4,204 | $47K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 45,031 | 30,720 | $47K |
| 97166 | 1,373 | 1,166 | $47K | |
| 97161 | 1,453 | 1,050 | $47K | |
| 36430 | 336 | 204 | $46K | |
| 86160 | 4,267 | 2,227 | $45K | |
| 10060 | 676 | 553 | $45K | |
| 96411 | 767 | 413 | $44K | |
| 85652 | 17,680 | 15,686 | $44K | |
| 82803 | 3,870 | 3,274 | $44K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 4,076 | 2,574 | $43K |
| P9047 | Infusion, albumin (human), 25%, 50 ml | 388 | 154 | $43K |
| 73120 | 661 | 544 | $43K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 839 | 815 | $42K |
| 92567 | 2,294 | 2,211 | $42K | |
| 72158 | 99 | 74 | $42K | |
| 58662 | 25 | 24 | $41K | |
| 83655 | 3,484 | 3,388 | $41K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 898 | 326 | $40K |
| 83525 | 4,121 | 3,889 | $40K | |
| 36561 | 51 | 26 | $40K | |
| 87077 | 6,317 | 4,718 | $39K | |
| 82140 | 3,736 | 2,787 | $39K | |
| 82785 | 2,352 | 2,031 | $38K | |
| 20610 | 825 | 408 | $38K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 9,599 | 7,599 | $38K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 82 | 76 | $37K |
| 86800 | 2,908 | 2,743 | $37K | |
| 95910 | 92 | 85 | $37K | |
| C1769 | Guide wire | 710 | 573 | $37K |
| 00952 | 316 | 284 | $36K | |
| 87493 | 1,493 | 1,330 | $36K | |
| 80076 | 5,182 | 3,889 | $36K | |
| 96523 | 1,272 | 1,070 | $36K | |
| 74019 | 684 | 643 | $35K | |
| 88313 | 249 | 220 | $35K | |
| 83516 | 2,591 | 1,506 | $34K | |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 562 | 518 | $34K |
| 80069 | 6,507 | 4,042 | $33K | |
| 00300 | 379 | 330 | $32K | |
| 74174 | 90 | 68 | $31K | |
| 90688 | 3,203 | 3,063 | $31K | |
| 64494 | 193 | 154 | $31K | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 6,098 | 2,612 | $31K |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 24 | 13 | $30K |
| 83001 | 1,945 | 1,808 | $30K | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 4,055 | 2,059 | $30K |
| 84481 | 2,151 | 2,026 | $30K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 172 | 167 | $29K |
| 72146 | 66 | 58 | $29K | |
| 72156 | 42 | 37 | $29K | |
| J1437 | Injection, ferric derisomaltose, 10 mg | 29 | 28 | $28K |
| C1781 | Mesh (implantable) | 302 | 228 | $28K |
| 87427 | 2,648 | 1,283 | $28K | |
| 54150 | 402 | 383 | $27K | |
| 84270 | 1,653 | 1,514 | $27K | |
| 90756 | 1,997 | 1,921 | $27K | |
| 84146 | 1,603 | 1,515 | $26K | |
| 58563 | 13 | 13 | $26K | |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 135 | 87 | $25K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 712 | 609 | $25K |
| 10005 | 85 | 66 | $25K | |
| 82550 | 4,178 | 3,214 | $24K | |
| 82784 | 3,954 | 3,081 | $24K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 2,905 | 1,381 | $24K |
| 97804 | 708 | 695 | $24K | |
| 87430 | 4,137 | 3,787 | $23K | |
| 77062 | 1,798 | 1,537 | $23K | |
| 84436 | 3,884 | 3,638 | $23K | |
| 93660 | 202 | 170 | $22K | |
| 87205 | 5,582 | 5,077 | $22K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 234 | 146 | $22K |
| 43249 | 83 | 39 | $22K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 4,501 | 3,767 | $21K |
| 82570 | 5,239 | 4,470 | $21K | |
| 76882 | 273 | 249 | $21K | |
| 84550 | 5,315 | 4,357 | $21K | |
| 73060 | 496 | 404 | $21K | |
| 96416 | 372 | 213 | $21K | |
| 82274 | 1,879 | 1,456 | $21K | |
| 00400 | 272 | 223 | $21K | |
| 84100 | 5,570 | 4,267 | $21K | |
| 86706 | 2,292 | 2,108 | $21K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 2,715 | 2,011 | $20K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 120 | 110 | $20K |
| 70470 | 143 | 129 | $20K | |
| 84132 | 2,391 | 1,901 | $20K | |
| 86200 | 2,019 | 1,863 | $20K | |
| 84681 | 1,209 | 1,125 | $20K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 84 | 81 | $20K |
| 86430 | 4,021 | 3,752 | $20K | |
| 72170 | 707 | 539 | $20K | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 343 | 286 | $20K |
| 86225 | 1,853 | 1,718 | $19K | |
| 87899 | 1,466 | 1,312 | $19K | |
| 86696 | 1,242 | 1,142 | $19K | |
| 90832 | Psychotherapy, 30 minutes with patient | 575 | 455 | $19K |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 28 | 27 | $19K |
| 86665 | 1,102 | 606 | $18K | |
| 87328 | 1,562 | 1,425 | $18K | |
| 80143 | 2,264 | 2,030 | $18K | |
| C1729 | Catheter, drainage | 1,201 | 464 | $18K |
| 84144 | 1,054 | 914 | $18K | |
| 92523 | 343 | 299 | $18K | |
| 93312 | 70 | 55 | $18K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 3,375 | 1,972 | $18K |
| 77061 | 1,712 | 1,378 | $17K | |
| 82150 | 2,990 | 2,759 | $17K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 221 | 207 | $17K |
| 80047 | 1,679 | 877 | $17K | |
| 99205 | Prolong outpt/office vis | 1,195 | 1,070 | $17K |
| 12001 | 356 | 303 | $17K | |
| 84156 | 5,338 | 4,649 | $17K | |
| 82950 | 3,936 | 3,661 | $17K | |
| 80179 | 2,167 | 1,954 | $17K | |
| 90686 | 7,105 | 6,906 | $16K | |
| 76937 | 94 | 78 | $16K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 26,625 | 20,014 | $16K |
| 86695 | 1,426 | 1,171 | $16K | |
| 88185 | 65 | 58 | $16K | |
| 86364 | 1,548 | 1,261 | $16K | |
| 86258 | 1,423 | 1,091 | $16K | |
| 74230 | 152 | 111 | $16K | |
| 99443 | 346 | 321 | $16K | |
| 83883 | 1,015 | 770 | $16K | |
| 86255 | 1,688 | 1,515 | $15K | |
| 82131 | 862 | 607 | $15K | |
| 84480 | 1,323 | 1,264 | $15K | |
| 80305 | 1,301 | 855 | $15K | |
| 92587 | 340 | 319 | $15K | |
| 87641 | 710 | 602 | $15K | |
| 51701 | 784 | 423 | $15K | |
| 72220 | 265 | 232 | $14K | |
| 73700 | 100 | 81 | $14K | |
| 87338 | 1,248 | 1,031 | $14K | |
| 86708 | 1,488 | 1,384 | $14K | |
| 80339 | 620 | 361 | $14K | |
| 77002 | 69 | 65 | $14K | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 622 | 436 | $14K |
| 99406 | 2,114 | 2,002 | $13K | |
| 87045 | 1,708 | 1,392 | $13K | |
| 84207 | 698 | 641 | $13K | |
| 87329 | 1,464 | 1,399 | $13K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 10,207 | 6,415 | $13K |
| 70360 | 181 | 165 | $13K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 2,123 | 1,839 | $13K |
| 72050 | 162 | 139 | $13K | |
| 86141 | 1,252 | 1,043 | $13K | |
| 01810 | 138 | 126 | $12K | |
| 86618 | 888 | 782 | $12K | |
| 83002 | 878 | 833 | $12K | |
| J0640 | Injection, leucovorin calcium, per 50 mg | 857 | 233 | $12K |
| 90670 | 5,713 | 5,547 | $12K | |
| 86757 | 706 | 386 | $12K | |
| 88112 | 309 | 253 | $12K | |
| 82565 | 1,464 | 992 | $12K | |
| J3480 | Injection, potassium chloride, per 2 meq | 2,172 | 1,223 | $12K |
| 90715 | 2,143 | 1,978 | $12K | |
| 96127 | 3,854 | 3,633 | $12K | |
| C1760 | Closure device, vascular (implantable/insertable) | 293 | 259 | $11K |
| 99305 | 599 | 486 | $11K | |
| 80164 | 1,208 | 1,038 | $11K | |
| 12002 | 233 | 199 | $11K | |
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml | 1,484 | 784 | $11K |
| 84425 | 597 | 560 | $11K | |
| 86704 | 1,135 | 1,016 | $11K | |
| 76010 | 780 | 721 | $11K | |
| 73551 | 596 | 502 | $10K | |
| 83615 | 2,385 | 2,039 | $10K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 245 | 155 | $10K |
| 85027 | 1,563 | 1,472 | $10K | |
| 83993 | 606 | 525 | $10K | |
| 80334 | 322 | 313 | $10K | |
| 80337 | 321 | 312 | $10K | |
| 88302 | 443 | 323 | $10K | |
| 72128 | 52 | 50 | $9K | |
| 42830 | 26 | 13 | $9K | |
| 73000 | 175 | 145 | $9K | |
| 72202 | 156 | 140 | $9K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 929 | 643 | $9K |
| J1170 | Injection, hydromorphone, up to 4 mg | 3,812 | 2,474 | $9K |
| 77001 | 62 | 52 | $9K | |
| 86664 | 666 | 619 | $9K | |
| 82533 | 633 | 542 | $9K | |
| 82977 | 1,432 | 1,233 | $8K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 2,831 | 2,151 | $8K |
| C9046 | Cocaine hydrochloride nasal solution (goprelto), 1 mg | 109 | 94 | $8K |
| 76942 | 40 | 38 | $8K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 6,063 | 4,361 | $8K |
| 82103 | 662 | 498 | $8K | |
| 87640 | 722 | 591 | $8K | |
| 82172 | 473 | 428 | $8K | |
| 72110 | 70 | 63 | $8K | |
| 82248 | 1,850 | 1,525 | $8K | |
| 97032 | 394 | 126 | $8K | |
| J2805 | Injection, sincalide, 5 micrograms | 202 | 186 | $8K |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 2,868 | 899 | $7K |
| 83520 | 762 | 463 | $7K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 9,050 | 5,325 | $7K |
| J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) | 225 | 207 | $7K |
| 97116 | 369 | 160 | $7K | |
| 84165 | 988 | 907 | $7K | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 32 | 31 | $7K |
| A9585 | Injection, gadobutrol, 0.1 ml | 229 | 192 | $7K |
| 86812 | 330 | 307 | $7K | |
| 83010 | 686 | 616 | $7K | |
| 72082 | 35 | 32 | $7K | |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 130 | 128 | $7K |
| 84112 | 222 | 194 | $7K | |
| 97012 | 548 | 179 | $7K | |
| 64495 | 52 | 44 | $7K | |
| C1776 | Joint device (implantable) | 13 | 13 | $6K |
| 86769 | 212 | 187 | $6K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,575 | 1,386 | $6K |
| 93798 | 258 | 25 | $6K | |
| 82105 | 554 | 513 | $6K | |
| 92526 | 246 | 78 | $6K | |
| J1815 | Injection, insulin, per 5 units | 2,816 | 1,352 | $6K |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 2,981 | 910 | $6K |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | 40 | 37 | $6K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 400 | 346 | $6K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 8,789 | 6,619 | $6K |
| 82247 | 1,155 | 893 | $6K | |
| 88173 | 85 | 64 | $6K | |
| 97035 | 186 | 82 | $6K | |
| 87210 | 996 | 926 | $5K | |
| 98960 | 181 | 166 | $5K | |
| 86147 | 210 | 104 | $5K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 15 | 12 | $5K |
| 99307 | 1,539 | 836 | $5K | |
| 72072 | 62 | 59 | $5K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 6,529 | 4,873 | $5K |
| 94727 | 154 | 148 | $5K | |
| 86039 | 482 | 465 | $5K | |
| 82525 | 546 | 469 | $5K | |
| 82378 | 374 | 329 | $5K | |
| 73718 | 14 | 12 | $5K | |
| J0248 | Injection, remdesivir, 1 mg | 32 | 12 | $5K |
| 82670 | 218 | 201 | $5K | |
| 64615 | 52 | 52 | $4K | |
| 96160 | 2,393 | 2,324 | $4K | |
| 82024 | 176 | 146 | $4K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 1,406 | 1,107 | $4K |
| J9190 | Injection, fluorouracil, 500 mg | 858 | 291 | $4K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 1,787 | 589 | $4K |
| 80370 | 112 | 98 | $4K | |
| 84432 | 359 | 308 | $4K | |
| 72120 | 93 | 78 | $4K | |
| 82010 | 902 | 691 | $4K | |
| C2617 | Stent, non-coronary, temporary, without delivery system | 134 | 115 | $4K |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 143 | 119 | $4K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 14 | 13 | $4K |
| 90837 | Psychotherapy, 53 minutes with patient | 95 | 25 | $4K |
| 86923 | 523 | 249 | $4K | |
| 29515 | 243 | 210 | $4K | |
| 87581 | 209 | 196 | $4K | |
| 90733 | 51 | 49 | $4K | |
| 99201 | 84 | 67 | $4K | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 1,036 | 824 | $4K |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | 539 | 513 | $4K |
| 86308 | 961 | 907 | $4K | |
| 00902 | 46 | 40 | $4K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 184 | 156 | $4K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 266 | 184 | $4K |
| 90651 | 726 | 712 | $4K | |
| 82627 | 170 | 158 | $3K | |
| 01400 | 42 | 28 | $3K | |
| 85018 | 1,639 | 1,164 | $3K | |
| J1940 | Injection, furosemide, up to 20 mg | 1,998 | 1,164 | $3K |
| 83521 | 304 | 201 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 125 | 112 | $3K |
| 73552 | 107 | 91 | $3K | |
| 84630 | 409 | 365 | $3K | |
| 83540 | 542 | 513 | $3K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 188 | 150 | $3K |
| 86787 | 352 | 308 | $3K | |
| 84520 | 782 | 723 | $3K | |
| 99177 | 834 | 819 | $3K | |
| 51702 | 57 | 52 | $3K | |
| 90632 | 84 | 80 | $3K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 906 | 681 | $3K |
| 72052 | 32 | 27 | $3K | |
| 81511 | 29 | 27 | $3K | |
| 84460 | 881 | 780 | $3K | |
| 86617 | 256 | 128 | $3K | |
| 82330 | 475 | 314 | $3K | |
| 97163 | 38 | 36 | $3K | |
| 80177 | 261 | 223 | $3K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 403 | 332 | $3K |
| 94664 | 236 | 217 | $3K | |
| A9270 | Non-covered item or service | 5,083 | 1,877 | $2K |
| 86334 | 172 | 169 | $2K | |
| 98966 | 1,035 | 470 | $2K | |
| J9263 | Injection, oxaliplatin, 0.5 mg | 150 | 41 | $2K |
| 86381 | 156 | 149 | $2K | |
| 87486 | 161 | 129 | $2K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,121 | 871 | $2K |
| 74220 | 13 | 12 | $2K | |
| 77012 | 13 | 12 | $2K | |
| 80202 | 185 | 113 | $2K | |
| 86682 | 205 | 190 | $2K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 2,856 | 2,308 | $2K |
| 90633 | 2,537 | 2,480 | $2K | |
| 92611 | 28 | 28 | $2K | |
| 82652 | 58 | 58 | $2K | |
| 85520 | 138 | 66 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 12 | 12 | $2K |
| 86666 | 207 | 130 | $2K | |
| 80171 | 92 | 81 | $2K | |
| 80346 | 180 | 176 | $2K | |
| 91322 | 42 | 38 | $2K | |
| C9113 | Injection, pantoprazole sodium, per vial | 1,132 | 597 | $2K |
| 80361 | 187 | 180 | $2K | |
| Q3014 | Telehealth originating site facility fee | 3,485 | 2,613 | $2K |
| 80349 | 112 | 106 | $2K | |
| 73100 | 28 | 15 | $2K | |
| J1953 | Injection, levetiracetam, 10 mg | 372 | 273 | $2K |
| 88184 | 90 | 59 | $2K | |
| 87517 | 61 | 61 | $2K | |
| 90480 | 68 | 66 | $2K | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 126 | 42 | $2K |
| 90723 | 3,013 | 2,927 | $2K | |
| 92610 | 46 | 38 | $2K | |
| 73600 | 32 | 25 | $2K | |
| 85384 | 376 | 340 | $2K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 756 | 445 | $2K |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 19 | 17 | $2K |
| 99381 | 41 | 37 | $2K | |
| 87536 | 31 | 26 | $1K | |
| 90697 | 1,533 | 1,502 | $1K | |
| 88142 | 90 | 89 | $1K | |
| 99195 | 46 | 39 | $1K | |
| 88312 | 26 | 24 | $1K | |
| 90658 | 293 | 286 | $1K | |
| 81241 | 57 | 50 | $1K | |
| 85014 | 510 | 290 | $1K | |
| 89051 | 323 | 213 | $1K | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 637 | 215 | $1K |
| 97164 | 52 | 51 | $1K | |
| 86015 | 140 | 132 | $1K | |
| 90734 | 700 | 681 | $1K | |
| 87449 | 84 | 67 | $1K | |
| 90648 | 3,049 | 2,957 | $1K | |
| 96161 | 702 | 657 | $1K | |
| 99336 | 37 | 32 | $1K | |
| 86359 | 48 | 39 | $1K | |
| 96401 | 82 | 27 | $1K | |
| 90677 | 1,417 | 1,397 | $1K | |
| 90681 | 834 | 807 | $1K | |
| 82390 | 138 | 124 | $1K | |
| J1643 | Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units | 1,422 | 506 | $1K |
| 99462 | 43 | 37 | $1K | |
| 70150 | 13 | 12 | $1K | |
| 73660 | 32 | 26 | $1K | |
| 92579 | 15 | 15 | $1K | |
| 82951 | 108 | 99 | $1K | |
| 97165 | 39 | 38 | $1K | |
| 82365 | 123 | 110 | $1K | |
| 80197 | 125 | 88 | $999.52 | |
| C1788 | Port, indwelling (implantable) | 18 | 12 | $992.72 |
| 82653 | 13 | 13 | $955.10 | |
| 86694 | 75 | 58 | $946.49 | |
| 82672 | 71 | 60 | $946.00 | |
| 90674 | 90 | 85 | $925.05 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 105 | 98 | $907.09 |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | 38 | 35 | $904.86 |
| 82671 | 37 | 37 | $890.27 | |
| 98940 | 92 | 33 | $881.59 | |
| 85613 | 139 | 115 | $838.48 | |
| 86318 | 53 | 51 | $828.37 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 134 | 65 | $827.94 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 12 | 12 | $824.23 |
| 97010 | 169 | 55 | $815.29 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 116 | 106 | $799.88 |
| 90710 | 423 | 418 | $788.20 | |
| 12011 | 28 | 27 | $729.43 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 218 | 208 | $710.40 |
| 80051 | 213 | 99 | $699.08 | |
| 99407 | 42 | 41 | $690.86 | |
| 85390 | 88 | 77 | $675.86 | |
| 80364 | 17 | 17 | $672.40 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 138 | 127 | $664.06 |
| J3360 | Injection, diazepam, up to 5 mg | 187 | 94 | $655.89 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,753 | 1,441 | $651.82 |
| 97014 | 77 | 28 | $649.14 | |
| J2060 | Injection, lorazepam, 2 mg | 1,674 | 1,134 | $635.57 |
| 90682 | 12 | 12 | $627.15 | |
| 99221 | 32 | 25 | $623.12 | |
| 86709 | 48 | 48 | $616.20 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 176 | 165 | $601.88 |
| 96402 | 23 | 13 | $570.56 | |
| 86705 | 54 | 54 | $566.08 | |
| 86360 | 32 | 27 | $555.27 | |
| 80324 | 19 | 18 | $508.25 | |
| 84479 | 101 | 99 | $506.36 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 1,333 | 986 | $503.70 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 385 | 297 | $485.75 |
| 90656 | 596 | 592 | $478.37 | |
| 86146 | 25 | 12 | $442.78 | |
| 84300 | 148 | 133 | $440.05 | |
| 86580 | 99 | 94 | $434.30 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 463 | 319 | $423.19 |
| 80359 | 13 | 13 | $413.52 | |
| 94667 | 29 | 25 | $401.27 | |
| 87625 | 37 | 36 | $396.14 | |
| 84450 | 131 | 108 | $387.22 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 161 | 143 | $378.69 |
| 86738 | 56 | 55 | $374.73 | |
| 85347 | 48 | 41 | $367.37 | |
| D1206 | Topical application of fluoride varnish | 29 | 26 | $360.00 |
| 84157 | 92 | 77 | $346.48 | |
| 84155 | 172 | 169 | $345.72 | |
| 99318 | 89 | 69 | $344.35 | |
| 90732 | 12 | 12 | $342.40 | |
| 82952 | 107 | 97 | $337.76 | |
| J2806 | Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms | 12 | 12 | $301.49 |
| 72020 | 15 | 12 | $299.12 | |
| 82595 | 49 | 39 | $287.70 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 1,065 | 719 | $275.58 |
| 87324 | 63 | 56 | $273.95 | |
| 85246 | 12 | 12 | $271.84 | |
| J0735 | Injection, clonidine hydrochloride, 1 mg | 94 | 69 | $262.67 |
| 80368 | 13 | 12 | $250.44 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 218 | 101 | $249.79 |
| 85240 | 15 | 14 | $230.02 | |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | 14 | 14 | $205.75 |
| 85045 | 79 | 70 | $201.56 | |
| 82787 | 21 | 12 | $190.28 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 29 | 27 | $170.60 |
| 83630 | 21 | 12 | $170.18 | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 70 | 25 | $164.43 |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 28 | 25 | $162.63 |
| 90680 | 865 | 847 | $160.90 | |
| 90716 | 40 | 39 | $154.61 | |
| 80365 | 27 | 27 | $144.90 | |
| 90696 | 157 | 156 | $144.00 | |
| 85397 | 12 | 12 | $142.94 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 12 | 12 | $141.50 |
| J1171 | Injection, hydromorphone, 0.1 mg | 134 | 90 | $134.51 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 515 | 348 | $132.61 |
| 99232 | Subsequent hospital care, per day, moderate complexity | 32 | 12 | $122.82 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 95 | 12 | $116.92 |
| 86431 | 31 | 25 | $114.97 | |
| 86316 | 13 | 12 | $111.44 | |
| 86735 | 13 | 12 | $100.48 | |
| 80178 | 26 | 25 | $99.36 | |
| 84311 | 48 | 44 | $97.69 | |
| 80175 | 13 | 13 | $97.59 | |
| 90647 | 464 | 456 | $96.89 | |
| 90707 | 40 | 39 | $90.94 | |
| J0592 | Injection, buprenorphine hydrochloride, 0.1 mg | 49 | 26 | $90.25 |
| A9284 | Spirometer, non-electronic, includes all accessories | 28 | 24 | $83.76 |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 20 | 12 | $83.32 |
| 29126 | 15 | 13 | $81.62 | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 13 | 13 | $81.20 |
| 83721 | 18 | 12 | $76.69 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 33 | 28 | $75.16 |
| J1630 | Injection, haloperidol, up to 5 mg | 278 | 229 | $72.53 |
| J0595 | Injection, butorphanol tartrate, 1 mg | 123 | 98 | $70.91 |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 651 | 424 | $66.79 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 115 | 112 | $65.13 |
| 81002 | 56 | 52 | $57.78 | |
| 83935 | 13 | 13 | $57.60 | |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 459 | 368 | $54.65 |
| 90687 | 78 | 75 | $50.36 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 129 | 25 | $49.22 |
| 94760 | 25 | 25 | $47.44 | |
| 99348 | 15 | 12 | $47.32 | |
| 94644 | 17 | 15 | $46.21 | |
| 36416 | 60 | 55 | $37.21 | |
| Q0245 | Injection, bamlanivimab and etesevimab, 2100 mg | 189 | 172 | $17.39 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 49 | 47 | $14.90 |
| G0008 | Administration of influenza virus vaccine | 308 | 289 | $11.93 |
| Q0247 | Injection, sotrovimab, 500 mg | 41 | 33 | $4.91 |
| 90700 | 62 | 58 | $3.64 | |
| Q0222 | Injection, bebtelovimab, 175 mg | 34 | 29 | $3.07 |
| 3078F | 4,746 | 4,528 | $0.00 | |
| 3077F | 610 | 572 | $0.00 | |
| 3725F | 26 | 26 | $0.00 | |
| 90380 | 12 | 12 | $0.00 | |
| 3074F | 5,386 | 5,080 | $0.00 | |
| 3079F | 4,481 | 4,264 | $0.00 | |
| 3080F | 126 | 124 | $0.00 | |
| 1126F | 54 | 47 | $0.00 | |
| 3075F | 2,094 | 1,986 | $0.00 | |
| 1111F | 32 | 31 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 14 | 13 | $0.00 |
| 90381 | 28 | 27 | $0.00 | |
| 99335 | 53 | 52 | $0.00 | |
| 95115 | 53 | 24 | $0.00 |